BIMI International Medical Inc.
BIMI · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $12 | $21 | $13 | $0 |
| % Growth | -44.5% | 66% | 8,030.9% | – |
| Cost of Goods Sold | $10 | $19 | $10 | $0 |
| Gross Profit | $2 | $2 | $2 | -$0 |
| % Margin | 16.5% | 11.4% | 19% | -92.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $11 | $6 | $5 | $1 |
| SG&A Expenses | $12 | $8 | $6 | $1 |
| Sales & Mktg Exp. | $1 | $2 | $1 | $0 |
| Other Operating Expenses | $5 | $0 | $0 | $1 |
| Operating Expenses | $17 | $8 | $6 | $2 |
| Operating Income | -$15 | -$8 | -$4 | -$1 |
| % Margin | -129.7% | -38% | -29.7% | -624.1% |
| Other Income/Exp. Net | -$6 | -$27 | $0 | -$1 |
| Pre-Tax Income | -$22 | -$35 | -$3 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$22 | -$35 | -$5 | -$4 |
| % Margin | -189.3% | -164.1% | -41.2% | -2,809.9% |
| EPS | -8.4 | -65.1 | -24.8 | -27.5 |
| % Growth | 87.1% | -162.5% | 9.8% | – |
| EPS Diluted | -8.4 | -65.1 | -24.8 | -27.5 |
| Weighted Avg Shares Out | 3 | 1 | 0 | 0 |
| Weighted Avg Shares Out Dil | 3 | 1 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3 | $2 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$18 | -$32 | -$3 | -$1 |
| % Margin | -151.9% | -150% | -25% | -802.7% |